Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00542776 · ClinicalTrials.gov registry record

Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine

A clinical trial of Inflammatory Bowel Disease (IBD) and Influenza Vaccine, sponsored by Boston Children's Hospital.

Completed
Registry status
146
Enrollment target
1
Study location

NCT00542776 is a study of Inflammatory Bowel Disease (IBD) and Influenza Vaccine that has completed, run by Boston Children's Hospital. The registered enrollment target is 146 participants, below the 262-participant average among 12 other Inflammatory Bowel Disease (IBD) trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00542776, a study of Inflammatory Bowel Disease (IBD) and Influenza Vaccine, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
146 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the efficacy and safety of influenza vaccine in patients with inflammatory bowel disease (IBD) on immunosuppressive therapy with IBD patients on aminosalicylates and healthy historical controls.

Interventions

  • OTHER blood draw

Study Locations (1)

Massachusetts

  • Children's Hospital Boston - Boston

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2007-10
Est. Completion 2008-02

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT00542776

The ClinicalTrials.gov registry entry for NCT00542776 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 12 other Inflammatory Bowel Disease (IBD) trials with a reported enrollment target (44% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Inflammatory Bowel Disease (IBD) appearing as the primary indexed condition, and to 1 intervention - of which blood draw is the first listed.

NCT00542776 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00542776 about?

NCT00542776 is a clinical study titled "Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine". The purpose of this study is to compare the efficacy and safety of influenza vaccine in patients with inflammatory bowel disease (IBD) on immunosuppressive therapy with IBD patients on aminosalicylates and healthy historical controls.

What is the current status of trial NCT00542776?

This trial is currently completed. The enrollment target is 146 participants. The study started on 2007-10. Estimated completion is 2008-02.

What conditions does trial NCT00542776 study?

This clinical trial studies the following conditions: Inflammatory Bowel Disease (IBD), Influenza Vaccine, Immunosuppressed or Non-Immunosuppressed, Antibody Titers, Seroprotective Titers.

What interventions are being tested in trial NCT00542776?

The interventions under investigation include: blood draw (OTHER).

Who is sponsoring clinical trial NCT00542776?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00542776 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammatory Bowel Disease (IBD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.